Transplant Monitoring Kits Market Overview
According to the latest research by Future Market Insights, Transplant Monitoring Kits Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031.
The Transplant Monitoring Kits will show growth due to the rising organ transplants globally and an increased number of donors to support the recipients’ transplantation. Therefore, growth at a significantly high CAGR will be expected soon.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13879
What is driving the Demand for Transplant Monitoring Kits?
The rising transplants globally are giving a major driving factor for the requirement of transplant monitoring kits. Among transplant recipients, non-adherence to immunosuppressive medications is a major cause of antibody-mediated rejection, which leads to graft loss.
Immunosuppressant non-adherence also contributes to the increased healthcare costs associated with acute rejection treatment, additional hospitalization, and kidney transplantation re-dialysis. Therefore, it is crucial to monitor post-transplantation who require long-term pharmacotherapy and prevent non-adherence.
Previous studies have reported that approximately 14–36% of kidney transplant recipients are non-adherent to immunosuppressive medications. The immune system is inclined to attack foreign organisms introduced to the body, and the body interprets a new organ as foreign.
Also, there has been significant growth in stem cell transplants for treating chronic diseases which will drive the market.
Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13879
Which factors are likely to augment the Growth of the Transplant Monitoring Kits Market?
According to a study, end-stage organ failure is estimated to affect more than six million people worldwide. Advancements in surgical techniques, immunosuppression, donor-recipient matching, and antimicrobial agents have all contributed to increasing patient success during transplant procedures.
Close monitoring of patients is essential after a transplant to ensure the body is not rejecting its new organ. The transplant patients usually receive therapeutic drugs post-transplant to help their bodies accept the new organ and remain healthy.
These therapeutic drugs require monitoring to make sure the patient is receiving the correct dosage for the greatest benefit without negative side effects or complications. As transplantation is the most favourable therapy for end-stage disease, the risk of rejection remains a constant concern.
Allograft rejection leads to a high risk of graft dysfunction, accompanied by a significantly higher probability of chronic failure and graft loss. This causes re-hospitalization and prolonged therapy or maybe death. Therefore it’s important to monitor the post-transplant.
The U.S. and Canada Transplant Monitoring Kits Market Outlook
U.S. and Canada will retain the top position in the market of Transplant Monitoring Kits due to the larger number of transplants taking in the region. According to the United Network for Organ Sharing, in 2019 in the U.S. 39,717 organ transplants were executed. This number is continuously rising as there has been an increase in live donor transplants.
According to Organ Procurement and Transplantation Network, there were a total of 5,725 living donor transplants were performed in 2020, a decrease of 22.6 percent over the record of 7,397 set in 2019 due to the COVID-19 outbreak.
Europe Demand Outlook for Transplant Monitoring Kits
Europe is seeing growth in advancement in the healthcare sector and an increase in demand for better healthcare providing opportunities will lead the transplant monitoring kits market in Europe.
According to EDQM and the Council of Europe, there were 34,221 organ transplants in Europe in 2018. There has been observance of increasing organ donors in the region making it possible for more transplants in the future.
This will result in developing the Transplant Monitoring Kits demand in Europe during the forecast period. Also, the support of the government for the treatment of chronic diseases and surgeries will lead to the adoption of transplants in the forecasted period.
Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-13879
Who are the Key Manufacturers and Suppliers of Transplant Monitoring Kits?
Some of the leading manufacturers and suppliers of Transplant Monitoring Kits include
- CareDx Inc.
- Thermo Fisher Scientific
- QIAGEN
- Hologic Inc.
- Eurofins Scientific
- JETA Molecular BV.
- ELITech Group SAS
- NateraInc.
- F. Hoffmann-La Roche Ltd
- Biocare Health Resources Inc.
- Bio-Rad LaboratoriesInc.
- Biogenuix Medsystems Pvt Ltd
- Genome Diagnostics B.V.
- Sanbio B.V.
- and others.
These companies followed certain strategies like partnership, collaboration, product launch, and mergers and acquisitions to gain a good position in the market. For instance, in June 2019, Eurofins Scientific acquired Transplant Genomics Inc., to improve the product line for improving organ transplant outcomes.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Key Segments
By Technology Type:
- Molecular Assay Technologies
- PCR-Based Molecular Assays
- Real-time PCR
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- PCR-Based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Other Sequencing-based Molecular Assays
- Non-molecular Assay Technologies
By Product:
- Reagents & Consumables
- Instruments
- Software & Services
By Application:
- Diagnostic Applications
- Pre-transplantation Diagnostics
- Infectious Disease Testing
- Histocompatibility Testing
- Blood Profiling
- Post-transplantation Diagnostics
- Pre-transplantation Diagnostics
- Research Applications
By Transplant Type:
- Solid Organ
- Stem Cell
- Soft Tissue
By End User:
- Independent Reference Laboratories
- Hospitals & Transplant Centres
- Research Laboratories & Academic Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- MEA
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs